Next-Level Care: Generative AI Poised for $22B Growth in Healthcare
Resumen
The generative artificial intelligence (AI) market for healthcare is valued at more than $1 billion as of 2022, and it is projected to swell to nearly $22 billion by 2032. Technology giants, venture capitalists and private equity firms will play a significant role in that market, acting as investors, partners and innovators. Meanwhile, healthcare companies — including providers, payers, pharmaceutical companies and others — recognize generative AI’s potential to transform health and medicine and are teaming up with tech giants and startups to introduce cutting-edge AI technology to all aspects of care — from research to treatment to billing. The “Generative AI Tracker®” delves into the current state and future potential of generative AI in healthcare. It explores various use cases, examines issues and challenges, and offers examples of emerging regulations. This edition highlights select startups addressing complex healthcare challenges, including drug discovery, patient care and clinical decisions. Generative AI Companies Stand Poised to Transform the Care Continuum Healthcare-focused companies and startups are turning to generative AI innovations to tackle complex drug discovery, diagnostic testing and patient care challenges. They are securing investments, emerging from stealth mode and announcing new clients. In some instances, they are also being acquired, following a pattern commonly seen when technology becomes more established. To learn more, visit the Tracker’s Companies of Note section. Generative AI Can Improve Medical Research, Drug Development and Patient Care Large language models (LLMs), the core of generative AI, offer many applications beyond drug discovery, promising to reshape other aspects of healthcare, including provider-patient interactions and care delivery. The U.S. Department of Health and Human Services (HHS) maintains a growing list of complex and detailed AI use cases deployed or in development within the federal government. To learn more, visit the Tracker’s Innovation and Use Cases section. Generative AI’s Technology Is Not Fully Optimized for Healthcare Generative AI faces many growing pains as it seeks its footing. In a recent survey, management consulting firm Bain & Company revealed that the main barriers to generative AI in healthcare are a lack of resources, expertise and regulation, with data access and quality and organizational resistance close behind. The recurring theme across industry studies is that generative AI in healthcare is nascent and needs time to prove its efficacy and to earn public trust. To learn more, visit the Tracker’s Issues and Challenges section. About the Tracker The “Generative AI Tracker®,” a collaboration with AI-ID, delves into the current state and future potential of generative AI in healthcare. This edition examines the role that generative AI can play in transforming critical aspects of healthcare, from research to treatment.The post Next-Level Care: Generative AI Poised for $22B Growth in Healthcare first appeared on PYMNTS.com.
Wio Bank PJSC, the region's first platform bank built to serve tomorrow’s customers, has announced its financial results for the fiscal year 2023, undersc…
Wio Bank PJSC, the region's first platform bank built to serve tomorrow’s customers, has announced its financial results for the fiscal year 2023, underscoring its rapid journey to profitability. As a leading choice for SMEs, the company reported a revenue of AED 266.4 million and a net profit of AED 2 million, marking its first full year of operations with impressive profitability since its launc...
A former managing director at Citigroup is suing the bank and COO for unlawful termination on the grounds of allegedly refusing to provide regulators with…
Ex-Citi employee files wrongful termination lawsuit alleging the bank hid data from regulators
Criptodivisas
Resumen
A former managing director at Citigroup is suing the bank and COO for unlawful termination on the grounds of allegedly refusing to provide regulators with false information.
Raqami Islamic Digital Bank Ltd. (RIDBL), one of five aspirants to the digital retail bank license under the Licensing and Regulatory Framework for Digita…
Raqami Islamic Digital Bank and 1LINK form partnership
Banca
Resumen
Raqami Islamic Digital Bank Ltd. (RIDBL), one of five aspirants to the digital retail bank license under the Licensing and Regulatory Framework for Digital Banks, 2022 is thrilled to announce a strategic partnership with 1LINK, Pakistan’s largest Payment Service Provider / Payment Service Operator. The signing ceremony took place at the 1LINK Office in Park Towers, Karachi and was attended by the...
Orca, a South African startup that works with banks and fintechs in emerging markets to fight various types of fraud, has raised a $550,000 pre-seed round…
Orca, a South African startup that works with banks and fintechs in emerging markets to fight various types of fraud, has raised a $550,000 pre-seed round. The money raised will be used to build simple, yet effective fraud prevention tools and iterate with customers in South Africa.
The British Business Bank has published the performance data for the third iteration of its Recovery Loan Scheme, highlighting its effectiveness in drivin…
British Business Bank Hails Third Iteration of Recovery Loan Scheme as ‘Important Intervention’
Criptodivisas
Resumen
The British Business Bank has published the performance data for the third iteration of its Recovery Loan Scheme, highlighting its effectiveness in driving growth for UK SMEs. The Recovery Loan Scheme is a government-backed credit guarantee scheme designed to support access to finance for UK businesses looking to invest and grow. Launched in August 2022, the third iteration of the Recovery Loan Scheme, looked to support the British Business Bank’s ongoing commitment to promote sustainable, accessible funding for UK smaller businesses, enabling them to invest and grow. The British Business Bank revealed that the total offered lending for this iteration surpassed £1.3billion, with over 6,000 smaller UK businesses drawing over £1.15billion of finance so far. The scheme aims to help smaller businesses across the UK, with a turnover of up to £45million, access finance they would have been unlikely to access commercially, on equivalent terms. Businesses can use the finance for any ‘legitimate business purpose’, such as managing cashflow, investing in new equipment or vehicles, perhaps to support the transition to net zero, and growth through new products or expansion. However, businesses must be able to afford to take out additional debt finance for these purposes. Overall, the scheme has been a success in targeting the smallest businesses, as the British Business Bank revealed over 90 per cent of the guaranteed facilities supported businesses with under 50 employees. Of this proportion, over 65 per cent of facilities went to businesses with fewer than 10 employees. Delivery working capital across the UK While the scheme supports firms with turnovers of up to £45million, the focus remained on those making less money – over 87 per cent of the guaranteed facilities supported businesses with less than £5million turnover. Reinald de Monchy, managing director of guarantee and wholesale solutions at British Business Bank Reinald de Monchy, managing director of guarantee and wholesale solutions at British Business Bank, said: “The Recovery Loan Scheme was an important intervention at a critical time for UK smaller businesses. What this data publication demonstrates is just how important it has been to delivering growth and working capital across our Nations and regions, and we are looking forward to its transition to the Growth Guarantee Scheme in Summer 2024.” More than half of drawn lending has been designated for business investment and growth purposes, and a third for working capital. The first two phases of the scheme, designed to support access to finance and growth for UK businesses as they recovered from the Covid-19 pandemic, enabled £4.3billion of finance. Jeremy Hunt, the Chancellor of the Exchequer, announced in the Spring Budget 2024 that the scheme, which was due to end on 30 June 2024, would be extended for two years until 31 March 2026, and renamed the Growth Guarantee Scheme. The post British Business Bank Hails Third Iteration of Recovery Loan Scheme as ‘Important Intervention’ appeared first on The Fintech Times.